Testing effectiveness (Phase 2)Not Yet RecruitingNCT07578467
What this trial is testing
Combining Neo-adjuvant ATR-inhibition With Nodal SBRT for Early-stage Resectable HPV+ OPSCCs
Who this might be right for
HPV Positive Oropharyngeal Squamous Cell CarcinomaSquamous Cell CarcinomaHPV (Human Papillomavirus)-Associated Carcinoma+2 more
Abramson Cancer Center at Penn Medicine 35